Related Experiment Video
Updated: May 18, 2026

A Lateralized Odor Learning Model in Neonatal Rats for Dissecting Neural Circuitry Underpinning Memory Formation
Published on: August 18, 2014
Blocking muscarinic receptors in the olfactory bulb impairs performance on an olfactory short-term memory task
Sasha Devore1, Laura C Manella, Christiane Linster
1Computational Physiology Laboratory, Department of Neurobiology and Behavior, Cornell University Ithaca, NY, USA.
Abstract:
Cholinergic inputs to cortical processing networks have long been associated with attentional and top-down processing. Experimental and theoretical studies suggest that cholinergic inputs to the main olfactory bulb (OB) can modulate both neural and behavioral odor discrimination. Previous experiments from our laboratory and others demonstrate that blockade of nicotinic receptors directly impairs olfactory discrimination, whereas blockade of muscarinic receptors only measurably impairs olfactory perception when task demands are made more challenging, such as when very low-concentration odors are used or rats are required to maintain sensory memory over long durations. To further investigate the role of muscarinic signaling in the OB, we developed an olfactory delayed match-to-sample task using a digging-based behavioral paradigm. We find that rats are able to maintain robust short-term odor memory for 10-100 s. To investigate the role of muscarinic signaling in task performance, we bilaterally infused scopolamine into the OB. We find that high dosages of scopolamine (38 mM) impair performance on the task across all delays tested, including the baseline condition with no delay, whereas lower dosages (7.6 mM and 22.8 mM) had no measureable effects. These results indicate that general execution of the match-to-sample task, even with no delay, is at least partially dependent on muscarinic signaling in the OB.
Insights
Cholinergic signaling in the olfactory bulb (OB) impacts odor discrimination. High doses of scopolamine disrupt olfactory task performance, indicating muscarinic signaling is crucial for OB function.
Area of Science:
- Neuroscience
- Olfactory system research
- Cholinergic system studies
Background:
- Cholinergic inputs are linked to attention and top-down processing in cortical networks.
- Cholinergic signaling in the main olfactory bulb (OB) influences neural and behavioral odor discrimination.
- Muscarinic receptor blockade impairs olfactory perception under demanding conditions.
Purpose of the Study:
- To investigate the role of muscarinic signaling in the OB using a behavioral olfactory task.
- To determine the effects of scopolamine, a muscarinic antagonist, on olfactory memory and task performance.
Main Methods:
- Developed an olfactory delayed match-to-sample task utilizing a digging-based behavioral paradigm in rats.
- Administered bilateral infusions of varying scopolamine dosages (7.6 mM, 22.8 mM, 38 mM) into the OB.
- Assessed task performance across different delay durations (0-100 s).
Main Results:
- Rats demonstrated robust short-term odor memory (10-100 s).
- High-dose scopolamine (38 mM) significantly impaired performance on the olfactory match-to-sample task at all delay intervals.
- Lower scopolamine dosages (7.6 mM and 22.8 mM) did not produce measurable effects on task performance.
Conclusions:
- Muscarinic signaling within the OB is essential for the general execution of olfactory match-to-sample tasks, even without a delay.
- These findings highlight the significant role of muscarinic pathways in olfactory bulb processing and odor-guided behavior.
Related Concept Videos
Olfactory Receptors: Location and Structure
Olfaction
The olfactory receptors are embedded in the cilia of the...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Physiology of Smell and Olfactory Pathway
The olfactory...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
